To the Editor: The one-stage prothrombin time played a significant part in the development of the modern clinical approach to the hemorrhagic diseases. This is again illustrated by the paper of Kroll ...

THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...

Hemophilia is diagnosed through a series of blood tests that evaluate clotting factors, clotting times, and genetic mutations. Clotting factor tests, a complete blood count (CBC), an activated partial ...